Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability and Immunogenicity Study of FLUVAL AB Influenza Vaccine in Adults and Elderly Persons
2012-002379-32Phase 4Completed
- Sponsor
- Omninvest
- Start
- May 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Fluval AB vaccine in influenza, sponsored by Omninvest. Primary endpoint: Immunogenicity objective. Started May 2012; status: completed.
02
Drugs
Fluval AB vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2012-002379-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002379-32.